Use of drug-coated balloons and stents in patients with femoropopliteal artery disease and severe chronic kidney disease

Vasc Med. 2023 Apr;28(2):150-152. doi: 10.1177/1358863X221148521. Epub 2023 Jan 29.

Authors

Yulanka Castro-Dominguez¹, Kim Smolderen^{2

3}, Gaelle Romain², Jeffrey Turner⁴, Carlos Mena-Hurtado²

Affiliations

¹ Harrington Heart & Vascular Institute, University Hospitals, Case Western Reserve University, Cleveland, OH, USA.
² Department of Medicine, Section of Cardiovascular Medicine, Vascular Medicine Outcomes Program (VAMOS), Yale School of Medicine, New Haven, CT, USA.
³ Department of Psychiatry, Yale School of Medicine, New Haven, CT, USA.
⁴ Department of Internal Medicine, Section of Nephrology, Yale School of Medicine, New Haven, CT, USA.

PMID: 36710497
DOI: 10.1177/1358863X221148521

No abstract available

Keywords: chronic kidney disease (CKD); drug-coated balloon; drug-eluting stent; peripheral artery disease (PAD).

Publication types

Letter

MeSH terms

Angioplasty, Balloon* / adverse effects
Coated Materials, Biocompatible
Femoral Artery / diagnostic imaging
Humans
Peripheral Arterial Disease* / diagnostic imaging
Peripheral Arterial Disease* / etiology
Peripheral Arterial Disease* / therapy
Popliteal Artery / diagnostic imaging
Popliteal Artery / surgery
Stents
Treatment Outcome
Vascular Patency

Substances

Coated Materials, Biocompatible